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Glycogen synthase from human and bovine polymorphonuclear leukocytes was purified to homogeneity. Rabbit antisera 
were raised against he two glycogen synthases and used for immunochemical nalysis. Western blotting analysis howed 
that the subunit of glycogen synthase in crude homogenates of human and bovine leukocytes in both cases has an M, 
of 85 000. The existence of a cross-reactivity between the two enzymes and the corresponding antisera demonstrates im- 
munological similarities between bovine and human leukocyte glycogen synthase. In addition, both antisera recognize 
glycogen synthase in crude cellular extracts from rabbit and rat liver and from skeletal muscle. Leukocyte glycogen 
synthase, therefore, cannot be classified as either muscle (M-type) or liver (L-type) glycogen synthase and our results 
do not support the proposed immunochemical distinction between M- and L-type glycogen synthase. 
Glycogen synthase; Polyclonal antibody; (Human leukocyte, Bovine leukocyte) 
1. INTRODUCTION 
Glycogen synthase (EC 2.4.1 .ll) is the rate- 
limiting enzyme in glycogen biosynthesis. Its ac- 
tivity is regulated by multi-site phosphorylation 
(review [l-4]). 
The enzyme from rabbit skeletal muscle is the 
best-characterized glycogen synthase. A minimum 
of 10 serine residues are phosphorylated by at least 
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9 protein kinases [5-81, and many were found (in 
the case of the muscle glycogen synthase) to reside 
close to the N- and C-termini of the enzyme [9]. 
The leukocyte enzyme is less well characterized 
than the muscle glycogen synthase. The enzyme 
purified from human as well as from bovine 
polymorphonuclear leukocytes has a subunit size 
of 85 kDa [lo, 111, and on HPLC the tryptic pep- 
tides which are phosphorylated by CAMP- 
dependent protein kinase co-migrate with the tryp- 
tic phosphopeptides of the enzyme from rabbit 
skeletal muscle containing sites la, lb and 2 [ 111. 
One must expect, therefore, a strong homology in 
the amino acid sequences around sites 1, lb and 2 
in leukocyte and rabbit skeletal muscle glycogen 
synthase. Comparison of the amino-acid sequences 
surrounding phosphorylation sites recognized by 
CAMP-dependent protein kinase in rabbit liver and 
skeletal muscle glycogen synthase showed that 
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these enzymes are isozymes [ 121. Immunoblot 
analysis has suggested that liver and muscle 
glycogen synthase are structurally different 
[ 13,141. They were termed L- (liver) and M- (mus- 
cle) type, respectively. Using immunoblot analysis, 
Rulfs et al. [ 151 have identified a glycogen synthase 
subunit of 93 kDa from rat heart and liver 
homogenates and have suggested that a purified 
glycogen synthase with subunit size around 85 kDa 
is proteolysed. Thus partial proteolysis must be 
considered when phosphorylation is being studied, 
because terminal sites may be lost during purifica- 
tion of the enzyme. However, by measuring the 
subunit size of purified enzyme and glycogen syn- 
thase in fresh homogenates, one can eliminate this 
problem. 
In this report, we describe the production and 
characterization of polyclonal antibodies against 
glycogen synthase from human and bovine 
polymorphonuclear leukocytes. Glycogen synthase 
in crude homogenates of human and bovine 
leukocytes were analyzed by Western immunoblot- 
ting. The molecular size was compared with the 
known M, value of the subunit of purified 
leukocyte glycogen synthase. Furthermore, the an- 
tibodies against leukocyte glycogen synthase were 
used to test cross-reactivity with glycogen synthase 
in crude cell extracts from rabbit and rat skeletal 
muscle and liver. 
2. MATERIALS AND METHODS 
2.1. Materials 
[U-‘4C]UDP-glucose, [y-32P]ATP and [‘*‘I]protein A were 
obtained from NEN Chemicals GmbH, FRG. Concanavalin A- 
Sepharose was a product of Pharmacia Fine Chemicals, 
Sweden. Nitrocellulose membrane (0.45 pm pore size) was from 
Millipore, USA. Benzamidine, soybean trypsin inhibitor, DTT, 
PMSF, and pre-stained molecular mass markers (SDS-7B) were 
from Sigma Chemical Company, USA. Acrylamide, 
bisacrylamide, and Nonidet P-40 were from BDH Chemicals, 
UK. TEMED and Coomassie blue G-250 were from Bio-Rad, 
USA. Semi-dry electroblotter was manufactured by Anchos, 
Denmark. 
2.2. Enzyme assay 
Glycogen synthase was assayed at 4 mM UDP-glucose in the 
absence (I-form) or presence (I+D-form) of 6.7 mM glucose 
6-phosphate [16]. The ratio of independence is the ratio be- 
tween the activities of the I-form and the I + D-forms. One unit 
(U) of glycogen synthase is the activity which incorporates 
1 rmol of glycosyl units from UDP-glucose into glycogen per 
min at 30°C. 
2.3. Electrophoretic purification of the glycogen synthase 
subunit 
Bovine and human polymorphonuclear leukocytes were 
isolated from fresh blood samples as described [17,18]. 
Glycogen synthase I from bovine and human polymor- 
phonuclear leukocytes were purified as described [l l] including 
affinity chromatography on concanavalin A-Sepharose. 
The glycogen synthase subunit which was used for immuniza- 
tion was isolated by extraction from SDS-polyacrylamide gels. 
Each lane contained 0.2 U (approx. 10/g) glycogen synthase 
and ‘*P-phosphorylated glycogen synthase as a marker. 
Autoradiograms of the wet gels were made and the gel sections 
containing the “*P-labelled glycogen synthase subunit (85 kDa) 
were cut out. In order to extract he glycogen synthase subunit, 
the gel pieces were homogenized with an Ultra-Turrax 
homogenizer for 10 s in 1 ml of 0.9% NaCl and placed on a 
rocking table at 20°C overnight. The gel material was removed 
by centrifugation through glasswool and protein concentration 
was determined in the extract. The solution was lyophilized and 
stored at -70°C until used for immunization. 
The protein concentration was determined by the Coomassie 
brilliant blue binding assay [19]. 
2.4. Antibody production 
Rabbit antisera were raised against electrophoretically 
purified glycogen synthase subunits from human and bovine 
polymorphonuclear leukocytes. A subcutaneous injection of 
50,ug of each antigen in Freund’s complete adjuvant was 
followed by an intravenous injection of 50 ,ug antigen in 0.9% 
NaCl 30 days later. 50 ml blood was recovered 10 days after. 
The immunization and bleeding were repeated at 30-day inter- 
vals and the serum from the fifth bleeding was used in the im- 
munoblotting experiments. 
2.5. Preparation of tissue extracts for immunoblotting 
experiments 
Leukocytes were isolated from fresh human and bovine 
blood samples as described [17,18]. A crude homogenate was 
obtained by ultrasonication as described [ 111. Rats and rabbits 
were killed by cervical dislocation and muscle and liver tissue 
were excised immediately and homogenized in 40 mM EDTA 
(pH 7.0), 50 mM KF, and 5% glycerol using an Ultra-Turrax 
homogenizer. The homogenates were centrifuged at 17000 x g 
for 30 min at 4°C. The supernatants were assayed for glycogen 
synthase activity and the remaining supernatants were mixed 
with SDS-sample buffer [20] and heated at 95°C for 5 min. 
Amounts as indicated in the figure legends were electrophoresed 
into 7.5% SDS-polyacrylamide gels, and transferred elec- 
trophoretically to nitrocellulose membranes by a semi-dry elec- 
troblotting technique [21] modified into a one-buffer system as 
described [22]. 
3. RESULTS AND DISCUSSION 
Glycogen synthase was purified from human 
and bovine polymorphonuclear leukocytes by af- 
finity chromatography on concanavalin A- 
Sepharose followed by SDS-polyacrylamide gel 
electrophoresis. In each case, the enzyme subunit 
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was identified as a protein band at 85 kDa by in- 
corporation of 32P-phosphate catalysed by CAMP- 
dependent protein kinase. The respective proteins 
were extracted from the gels as described in section 
2.2 and used to immunise rabbits. The immune 
response was followed by rocket immunoelec- 
trophoresis of glycogen synthase in agarose gels 
containing the serum. Immune serum obtained 
after five immunisations was used in Western blot- 
ting analysis of glycogen synthase. 
Crude protein extracts from human leukocytes 
were separated by 1-D SDS-polyacrylamide gel 
electrophoresis, electroblotted onto nitrocellulose 
and analysed with rabbit antiserum against human 
leukocyte glycogen synthase. Fig.lA shows the 
result of such a Western blot. A similar experiment 
in which antiserum against bovine leukocyte 
glycogen synthase was used is shown in fig;lB. Out 
of the vast diversity of proteins in the 17000 x g 
supernatants, both antisera recognize only one 
protein band of 85 kDa. The antisera also 
recognize an 85 kDa band in concanavalin A- 
Sepharose purified glycogen synthase from human 
and bovine leukocytes (not shown). Control ex- 
periments using sera from the rabbits before im- 
munization did not show any cross-reactivity with 
crude leukocyte extracts (data not shown). The 
absence of protein bands at higher A4, indicates 
that the native subunit of human and bovine 
leukocyte glycogen synthase has an Mr of 85000, 
identical to the M, value for the purified leukocyte 
glycogen synthase [ 10,111. The antisera recognize 
both human and bovine leukocyte synthase, show- 
ing that these enzymes are immunologically 
similar. 
In addition to human and bovine glycogen syn- 
thase (fig.l), the antisera recognized proteins in 
rabbit and rat liver and muscle homogenates 
(fig.2). The cross-reactivity between leukocyte and 
muscle glycogen synthase is in agreement with our 
previous findings that tryptic phosphopeptides 
(sites la, lb and 2) from leukocyte and rabbit mus- 
cle glycogen synthase appear identical when 
analysed by HPLC [l 11. The 90 kDa band found 
Fig. 1. Western blot analysis of crude protein extracts from human leukocytes using rabbit antiserum against human leukocyte glycogen 
synthase (A) or rabbit antiserum against bovine leukocyte glycogen synthase (B). Increasing amounts of 17000 x g supernatant from 
human polymorphonuclear leukocytes were run in a 7.5% polyacrylamide gel and electrophoretically transferred to nitrocellulose as 
described in section 2. The amount of glycogen synthase in the crude cell extract was determined by the activity assay as described 
in section 2. The lanes contain (from left to right) 5, 10, 15, 25, 50 and 100 mu. Standard M, markers were cy-2-macroglobulin 
(180 kDa), fl-galactosidase (116 kDa), fructose-6-phosphate kinase (84 kDa), pyruvate kinase (58 kDa) and fumarase (48.5 kDa). 
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Fig.2. Western blot analysis of glycogen synthase in crude 
protein extracts from rabbit and rat muscle and liver. The SDS- 
polyacrylamide gel electrophoresis and immunoblotting were as 
described in section 2 and in the legend to fig.1. Lane 1, 
17000 x g supernatant of rabbit muscle; lane 2, 17000 x g 
supernatant of rabbit liver; lane 3, 17000 x g supernatant of rat 
muscle; lane 4, 17OOU x g supernatant of rat liver. The amount 
of glycogen synthase in the crude cell extracts was determined 
by the activity assay as described in section 2. Each lane 
contained 50 mu. 
in the Western blot of crude rabbit and rat muscle 
extracts (fig.2, lanes 1 and 3) corresponds to the 
molecular mass of muscle glycogen synthase 
[23-251. The 56 kDa band has been observed by 
Recent investigations of liver glycogen synthase 
revealed subunit sizes in the range 75-93 kDa 
others and found to contain a proteolytic fragment 
[ 14,151. Our antisera recognized predominantly a 
protein of 74 kDa in the crude liver extracts (fig.2, 
lanes 2 and 4). The occurrence of lower-M, forms 
of the 90 kDa form [6]. 
of glycogen synthase is considered to be due to par- 
tial proteolysis, for two reasons: (i) no protease in- 
hibitors were added to the buffer used for 
homogenization of the rabbit and rat tissues and 
(ii) it has been shown that the glycogen synthase 
subunit is susceptible to proteolysis [9,15,26]. 
Because our antisera thus recognize glycogen 
synthase in liver and muscle, these tissues must 
contain an enzyme that resembles the leukocyte 
enzyme. 
On the basis of immunochemical analysis using 
antisera against rat liver and skeletal muscle, 
Kaslow and co-workers have proposed the ex- 
istence of two isozymes in these tissues. In Western 
blotting analysis, Kaslow found no immunological 
cross-reactivity and concluded that specific L-type 
(liver) and M-type (muscle) enzymes must exist 
[13,14]. However, other workers found that 
specific antibodies to rabbit skeletal muscle 
precipitate both rabbit and rat liver glycogen syn- 
thase in addition to the muscle enzyme [27,28]. 
Furthermore, it was found that monospecific an- 
tiserum to rat heart muscle glycogen synthase was 
able to recognize both rat heart and rat liver syn- 
thase [15]. These findings, together with our 
results from the study of leukocyte glycogen syn- 
thase, do not support the general hypothesis that 
L- and M-type enzymes can be distinguished by im- 
munochemical analysis. 
A similar study is needed for further classifica- 
tion of leukocyte glycogen synthase and for a bet- 
ter understanding of the heterogeneity of the 
enzyme. We are at present studying the amino acid 
sequences of phosphopeptides from leukocyte 
glycogen synthase. 
In any case, we must conclude that leukocyte 
glycogen synthase cannot be classified as either 
muscle (M-) or liver (L-) type glycogen synthase ac- 
cording to the nomenclature stated in 113,141. 
However, differences have been found in the 
amino-acid sequences urrounding the sites which 
are recognized by CAMP-dependent protein kinase 
(sites la, lb and 2), showing that glycogen syn- 
thase from rabbit muscle and liver are isozymes 
WI. 
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